Susquehanna International Group, LLP Relmada Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$641 Billion
Q4 2024

A detailed history of Susquehanna International Group, LLP transactions in Relmada Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 209,900 shares of RLMD stock, worth $79,762. This represents 0.0% of its overall portfolio holdings.

Number of Shares

209,900

Previous 41,730 403.0%

Holding current value

$79,762

Previous $135,000 19.26%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.3 - $4.36 $60,733 - $115,130	-26,406 Reduced 38.75%	41,730 $135,000
Q2 2024 Aug 15, 2024	BUY	$2.93 - $4.94 $122,406 - $206,378	41,777 Added 158.49%	68,136 $204,000
Q1 2024 May 07, 2024	SELL	$3.1 - $6.8 $52,284 - $114,688	-16,866 Reduced 39.02%	26,359 $122,000
Q4 2023 Feb 14, 2024	BUY	$2.45 - $4.22 $32,717 - $56,353	13,354 Added 44.71%	43,225 $178,000
Q3 2023 Nov 14, 2023	SELL	$2.48 - $3.79 $77,948 - $119,123	-31,431 Reduced 51.27%	29,871 $89,000
Q2 2023 Aug 11, 2023	SELL	$2.22 - $3.54 $37,322 - $59,514	-16,812 Reduced 21.52%	61,302 $150,000
Q1 2023 May 16, 2023	SELL	$2.24 - $4.76 $175,349 - $372,617	-78,281 Reduced 50.05%	78,114 $176,000
Q4 2022 Feb 14, 2023	BUY	$2.17 - $35.84 $254,708 - $4.21 Million	117,377 Added 300.83%	156,395 $545,000
Q3 2022 Nov 14, 2022	BUY	$18.3 - $37.02 $714,029 - $1.44 Million	39,018 New	39,018 $1.44 Million
Q4 2021 Feb 14, 2022	SELL	$16.93 - $26.82 $195,964 - $310,441	-11,575 Reduced 33.23%	23,255 $524,000
Q3 2021 Nov 15, 2021	SELL	$21.86 - $34.77 $726,429 - $1.16 Million	-33,231 Reduced 48.83%	34,830 $913,000
Q2 2021 Aug 11, 2021	BUY	$29.55 - $39.15 $197,482 - $261,639	6,683 Added 10.89%	68,061 $2.18 Million
Q1 2021 May 17, 2021	BUY	$31.52 - $39.28 $1.56 Million - $1.95 Million	49,622 Added 422.1%	61,378 $2.16 Million
Q4 2020 Feb 16, 2021	SELL	$29.88 - $39.8 $2.15 Million - $2.86 Million	-71,810 Reduced 85.93%	11,756 $377,000
Q1 2020 May 15, 2020	BUY	$23.78 - $50.12 $1.57 Million - $3.31 Million	65,967 Added 374.83%	83,566 $2.85 Million
Q4 2019 Feb 14, 2020	BUY	$10.1 - $47.18 $177,749 - $830,320	17,599 New	17,599 $686,000

Others Institutions Holding RLMD

# of Institutions

Shares Held

8.32M

Call Options Held

364K

Put Options Held

46.5K

View Full List

About RELMADA THERAPEUTICS, INC.

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $10.9M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

More about RLMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Relmada Therapeutics, Inc. Transaction History